TerminatedNot Applicable

Screening for Fabry Disease in Renal Transplantation

Stopped: Low recreuitement numbers and end of grant.

France592 participantsStarted 2019-03-25

Plain-language summary

Single centre, prospective pilot study examining the relevance to screen for Fabry disease in a cohort of patients who have undergone renal transplantation for nephropathy of indeterminate cause, vascular nephropathy, diabetic nephropathy or secondary focal segmental hyalinosis with no established cause.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Nephropathy of indeterminate cause, or secondary FSH or diabetic nephropathy * Patients with kidney transplanted * Patients still followed at the Montpellier University Hospital * Obtaining written informed consent * Age \> 18 years old, no upper age limit Exclusion Criteria: * N/A

What they're measuring

Number of Patients with Positive screen result

Timeframe: Inclusion visit

Trial details

NCT IDNCT03886714

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31

View on ClinicalTrials.gov More Fabry Disease trials